Detalhe da pesquisa
1.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10404): 775-785, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516125
2.
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
N Engl J Med
; 377(1): 28-40, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28525302
3.
Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors.
Proc Natl Acad Sci U S A
; 110(28): 11523-8, 2013 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798428
4.
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
Obstet Gynecol
; 132(1): 147-160, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29889764